Skip to main content
. 2024 Mar 20;7(3):e2038. doi: 10.1002/cnr2.2038

TABLE 5.

HRQoL according to the treatment modalities.

Good HRQoL (mean score ≥ 60) frequency, N (%) Poor HRQoL (mean score < 60) frequency, N (%)
Esophageal cancer (n = 160)
Esophagectomy 13 (8.1) 36 (22.5)
Chemotherapy and radiotherapy 8 (5.0) 24 (15.0)
Chemotherapy 2 (1.3) 4 (2.5)
Radiotherapy 1 (0.6) 16 (10.0)
Esophagectomy and chemotherapy 1 (0.6) 2 (1.3)
Symptomatic management 10 (6.3) 20 (12.5)
Radiotherapy, chemotherapy and esophagectomy 2 (1.3) 9 (5.6)
Radiotherapy and esophagectomy 5 (3.1) 7 (4.3)
Gastric cancer (n = 103)
Gastrectomy 5 (4.9) 18 (17.5)
Chemotherapy and radiotherapy 2 (1.9) 4 (3.9)
Chemotherapy 8 (7.8) 28 (27.2)
Radiotherapy 0 (0.0) 1 (1.0)
Gastrectomy and chemotherapy 3 (2.9) 10 (9.7)
Symptomatic management 9 (8.7) 11 (10.7)
Radiotherapy, chemotherapy and gastrectomy 1 (1.0) 3 (2.9)
Colorectal cancer (n = 96)
Surgery 5 (5.2) 7 (7.3)
Chemotherapy and radiotherapy 7 (7.3) 9 (9.4)
Chemotherapy 3 (3.1) 18 (18.8)
Radiotherapy 0 (0.0) 1 (1.0)
Surgery and chemotherapy 4 (4.2) 21 (21.9)
Symptomatic management 1 (1.0) 5 (5.2)
Radiotherapy, chemotherapy and surgery 4 (4.2) 11 (11.5)

Abbreviation: HRQoL, health‐related quality of life.